Suvi T. Vaara

5.5k citations

62 papers · 2.3k indexed · 1 hit paper · h-index 21

Nephrology top 0.2%
Epidemiology top 5%
Critical Care and Intensive Care Medicine top 0.5%
Surgery top 5%
Emergency Medicine top 2%

Co-authors: Ville Pettilä Matti Reinikainen Rinaldo Bellomo Kirsi‐Maija Kaukonen Sean M. Bagshaw Anna‐Maija Korhonen Ron Wald Outi Inkinen
Topics: Acute Kidney Injury Research (48 papers)Sepsis Diagnosis and Treatment (29 papers)Trauma, Hemostasis, Coagulopathy, Resuscitation (19 papers)
Cited by: Nephrology Critical Care and Intensive Care Medicine Emergency Medicine
Journals: Nature Communications PLoS ONE Scientific Reports
Partner nations: Finland Australia United States

In The Last Decade

Suvi T. Vaara

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute kidney injury in sepsis

2017 534 citations Rinaldo Bellomo, Ron Wald et al. Intensive Care Medicine profile →

Peers

Countries citing papers authored by Suvi T. Vaara

Since Specialization

Citations

This map shows the geographic impact of Suvi T. Vaara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi T. Vaara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi T. Vaara more than expected).

Fields of papers citing papers by Suvi T. Vaara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi T. Vaara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi T. Vaara. The network helps show where Suvi T. Vaara may publish in the future.

Co-authorship network of co-authors of Suvi T. Vaara

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi T. Vaara. A scholar is included among the top collaborators of Suvi T. Vaara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi T. Vaara. Suvi T. Vaara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis 2024 ·Critical Care Explorations ·Suvi T. Vaara,Ary Serpa Neto,Rinaldo Bellomo,Neill K. J. Adhikari,Didier Dreyfuss,Martin Gallagher,Stéphane Gaudry,Eric A. J. Hoste,Michael Joannidis,Ville Pettilä,Ying Wang,Kianoush Kashani,Ron Wald,Sean M. Bagshaw,Marlies Ostermann,(unknown)	5
2	Fluid bolus increases plasma hyaluronan concentration compared to follow-up strategy without a bolus in oliguric intensive care unit patients 2024 ·Scientific Reports ·(unknown),(unknown),Päivi Lakkisto,Miia Valkonen,Anni Pulkkinen,Tuomas Selander,Ville Pettilä,Suvi T. Vaara	0
3	The effect of higher or lower mean arterial pressure on kidney function after cardiac arrest: a post hoc analysis of the COMACARE and NEUROPROTECT trials 2023 ·Annals of Intensive Care ·Johanna Laurikkala,Koen Ameloot,Matti Reinikainen,Pieter‐Jan Palmers,C. De Deyne,(unknown),Matthias Dupont,Stefan Janssens,Joseph Dens,Johanna Hästbacka,Pekka Jakkula,Pekka Loisa,Thomas Birkelund,Erika Wilkman,Suvi T. Vaara,Markus B. Skrifvars	2
4	Generalized precursor prediction boosts identification rates and accuracy in mass spectrometry based proteomics 2023 ·Communications Biology ·(unknown),Christofer Karlsson,Tirthankar Mohanty,(unknown),Suvi T. Vaara,Adam Linder,Johan Malmström,Lars Malmström	5
5	Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial 2022 ·Critical Care ·Ron Wald,(unknown),Bruno R. da Costa,(unknown),Neill K. J. Adhikari,William Beaubien–Souligny,Rinaldo Bellomo,Martin Gallagher,Stuart L. Goldstein,Eric A. J. Hoste,Kathleen D. Liu,Javier A. Neyra,Marlies Ostermann,Paul M. Palevsky,Antoine Schneider,Suvi T. Vaara,Sean M. Bagshaw	14
6	Non-interventional follow-up versus fluid bolus in RESPONSE to oliguria in hemodynamically stable critically ill patients: a randomized controlled pilot trial 2022 ·Critical Care ·(unknown),Ville Pettilä,Miia Valkonen,(unknown),Minna Bäcklund,Johanna Hästbacka,Anni Pulkkinen,Tuomas Selander,Suvi T. Vaara	9
7	Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial 2020 ·Critical Care and Resuscitation ·Luca Cioccari,Nora Luethi,Thy Duong,Eileen Ryan,Salvatore Lucio Cutuli,(unknown),Glenn M. Eastwood,Leah Peck,Helen Young,Suvi T. Vaara,Craig French,Neil Orford,(unknown),Yugeesh R. Lankadeva,Michael Bailey,Gavin E. Reid,Rinaldo Bellomo	5
8	Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study 2020 ·Critical Care ·Renske Wiersema,Sakari Jukarainen,Ruben J. Eck,Thomas Kaufmann,Jacqueline Koeze,Frederik Keus,Ville Pettilä,Iwan C.C. van der Horst,Suvi T. Vaara	41
9	Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort 2020 ·Critical Care ·(unknown),Eric A. J. Hoste,Suvi T. Vaara,(unknown),Mikko Haapio,Lieve Nuytinck,Kristel Demeyere,Ville Pettilä,Evelyne Meyer	20
10	Heme oxygenase-1 repeat polymorphism in septic acute kidney injury 2019 ·PLoS ONE ·(unknown),Suvi T. Vaara,Kati Donner,Päivi Lakkisto,Mari Kaunisto,Ville Pettilä,(unknown)	14
11	Burden of acute kidney injury and 90-day mortality in critically ill patients 2019 ·BMC Nephrology ·Renske Wiersema,Ruben J. Eck,Mikko Haapio,Jacqueline Koeze,Meri Poukkanen,Frederik Keus,Iwan C.C. van der Horst,Ville Pettilä,Suvi T. Vaara	44
12	Extra-Renal Indications for Continuous Renal Replacement Therapy 2018 ·Contributions to nephrology ·Suvi T. Vaara,Rinaldo Bellomo	10
13	Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury 2017 ·Annals of Intensive Care ·(unknown),(unknown),Suvi T. Vaara,Jane Fisher,Meri Poukkanen,Ville Pettilä,Adam Linder	34
14	Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study 2016 ·Annals of Intensive Care ·(unknown),(unknown),Ville Pettilä,Anna‐Maija Korhonen,Sari Karlsson,Tero Ala‐Kokko,Matti Reinikainen,Suvi T. Vaara	10
15	Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic review 2016 ·Thrombosis Research ·Annukka Vahtera,Suvi T. Vaara,Ville Pettilä,Anne Kuitunen	13
16	Soluble CD73 in Critically Ill Septic Patients – Data from the Prospective FINNAKI Study 2016 ·PLoS ONE ·Suvi T. Vaara,Maija Hollmén,Anna‐Maija Korhonen,Mikael Maksimow,Tero Ala‐Kokko,Marko Salmi,Sirpa Jalkanen,Ville Pettilä,(unknown)	8
17	Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased Mortality 2016 ·Journal of Cardiothoracic and Vascular Anesthesia ·Liisa Petäjä,Suvi T. Vaara,(unknown),Raili Suojaranta-Ylinen,Leena Mildh,Sara Nisula,Anna‐Maija Korhonen,Kirsi‐Maija Kaukonen,Markku Salmenperä,Ville Pettilä	40
18	Timing of RRT Based on the Presence of Conventional Indications 2014 ·Clinical Journal of the American Society of Nephrology ·Suvi T. Vaara,Matti Reinikainen,Ron Wald,Sean M. Bagshaw,Ville Pettilä	53
19	Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study 2013 ·Intensive Care Medicine ·(unknown),Sara Nisula,Kirsi‐Maija Kaukonen,Suvi T. Vaara,Anna‐Maija Korhonen,Meri Poukkanen,Sari Karlsson,Mikko Haapio,Outi Inkinen,Ilkka Parviainen,Raili Suojaranta-Ylinen,Jouko J. Laurila,Jyrki Tenhunen,Matti Reinikainen,Tero Ala‐Kokko,Esko Ruokonen,Anne Kuitunen,Ville Pettilä	295
20	Association of ICU size and annual case volume of renal replacement therapy patients with mortality 2012 ·Acta Anaesthesiologica Scandinavica ·Suvi T. Vaara,Matti Reinikainen,Kirsi-Maija Kaukonen,Ville Pettilä	13

About Suvi T. Vaara

Suvi T. Vaara is a scholar working on Nephrology, Critical Care and Intensive Care Medicine and Emergency Medicine, having authored 62 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (48 papers), Sepsis Diagnosis and Treatment (29 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (19 papers). The work is most often cited by research in Nephrology (1.5k citations), Critical Care and Intensive Care Medicine (641 citations) and Emergency Medicine (387 citations). Suvi T. Vaara has collaborated with scholars based in Finland, Australia and United States. Frequent co-authors include Ville Pettilä, Matti Reinikainen, Rinaldo Bellomo, Kirsi‐Maija Kaukonen, Sean M. Bagshaw, Anna‐Maija Korhonen, Ron Wald, Outi Inkinen, Meri Poukkanen and Sara Nisula. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact